Big Cap Biotech Recovery

I think it's time to jump back into the big cap biotech's. They’ve been through a nice correction, consolidated and starting to move up once again. Take a look at the biotech exchange traded fund, BBH (Ticker: BBH). The top five holdings in the BBH: Genentech (Ticker: DNA), Amgen (Ticker: AMGN), Gilead Sciences (Ticker: GILD), Biogen Idec (Ticker: BIIB) and Genzyme (Ticker: GENZ) make up ~ 85% of the fund. The chart of BBH looks great right now with the down trend broken. I don’t like the small cap biotech’s as much since they are following the big caps and are not leading this biotech recovery.

Here's a chart of the BBH: